Low dosis of alteplase, for ischemic stroke after Enchanted and its determinants, a single center experience

Autor: Enrico Mazzon, Alexis Rojo, Gabriel Cavada, Paula Muñoz-Venturelli, Verónica V. Olavarría, Juan Almeida, Eloy Mansilla, Alejandro M. Brunser, Pablo M. Lavados
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Arquivos de Neuro-Psiquiatria, Vol 78, Iss 11, Pp 681-686 (2020)
Arquivos de Neuro-Psiquiatria v.78 n.11 2020
Arquivos de neuro-psiquiatria
Academia Brasileira de Neurologia
instacron:ABNEURO
Arquivos de Neuro-Psiquiatria, Volume: 78, Issue: 11, Pages: 681-686, Published: 14 DEC 2020
ISSN: 1678-4227
Popis: Background: Low-dose alteplase (LrtPA) has been shown not to be inferior to the standard-dose (SrtPA) with respect to death/disability. Objective: We aim to evaluate the percentage of patients treated with LrtPA at our center after the ENCHANTED trial and the factors associated with the use of this dosage. Methods: Prospective study in consecutive patients with an acute stroke admitted between June 2016 and November 2018. Results: 160 patients were treated with intravenous thrombolysis, 50% female; mean age 65.4±18.5 years. Of these, 48 patients (30%) received LrtPA. In univariate analysis, LrtPA was associated with patient's age (p=0.000), previous modified Rankin scale scores (mRS) (p
Databáze: OpenAIRE